Werner MeierChief Scientific Officer and Acting CEO at Revitope OncologySpeaker
Profile
Revitope Oncology: Chief Scientific Officer and acting CEO Biogen: Vice President of Biologics Drug Discovery, responsible for developing therapeutic protein drug candidates. Program Executive of two development programs aimed at treating immunologic and neurological diseases Applied BioMath and Institute for Protein Innovation: Scientific board member